Showing results (281-290 of 313) with videos related to

Sort By:
Pageof 32
The Kurume Medical Journal|May 17, 2000
Epidemiological study on food intake and Helicobacter pylori infectionA Toyonaga, H Okamatsu, K Sasaki, et al.
Cancer Research|November 15, 1993
A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinomaK Taketa, Y Endo, C Sekiya, et al.
The Kurume Medical Journal|January 1, 1995
Clinical evaluation of intramuscular administration of natural interferon-gamma in the treatment of chronic hepatitis BM Sata, T Matsushima, S Kakumu, et al.
The Kurume Medical Journal|January 1, 1997
Effects of interferon alpha 2a on incidence of hepatocellular carcinoma in chronic active hepatitis without cirrhosis. Hepatitis Treatment Study GroupM Sata, T Ide, F Akiyoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[Continuous arterial infusion of low-dose cisplatin, 5-fluorouracil as adjuvant therapy in cytoreductive surgery for advanced hepatocellular carcinoma]T Ogata, K Okuda, S Tanaka, et al.
Journal of Hepatology|July 1, 1994
The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: immunohistochemical analysisT Torimura, T Ueno, S Inuzuka, et al.
Gastrointestinal Endoscopy|May 1, 1993
Gastric mucosal blood flow after smoking in healthy human beings assessed by laser Doppler flowmetryT Iwao, A Toyonaga, M Ikegami, et al.
The Kurume Medical Journal|January 1, 1995
A case of acute exacerbation of chronic hepatitis B accompanied by antibody to HBeAg with remission of liver damage after long-term treatment with interferonH Muraoka, T Sanefuji, R Keida, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1996
Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regressionR Kumashiro, M Sata, K Ishii, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1989
[An assessment of therapeutic effects by transcatheter arterial embolization (TAE) with degradable starch microspheres (DSM) for hepatic malignant tumors]K Hirai, K Yamashita, Y Aoki, et al.
Pageof 32